Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7142674 | 0.97 | ALDH1A1 (0.33) | ALDH1A1GAATSHR | |
| Trifosmin SCHEMBL8406572 | 0.97 | ALDH1A1 (0.33) | ALDH1A1GAATSHR | |
| SCHEMBL5270639 | 0.90 | ALDH1A1 (0.39) | ALDH1A1GAATSHR | |
| SCHEMBL18486622 | 0.88 | ALDH1A1 (0.42) | ALDH1A1GAA | |
| SCHEMBL18486666 | 0.88 | ALDH1A1 (0.42) | ALDH1A1GAA | |
| SCHEMBL18486498 | 0.88 | ALDH1A1 (0.42) | ALDH1A1GAA | |
| SCHEMBL18486516 | 0.88 | ALDH1A1 (0.42) | ALDH1A1GAA | |
| SCHEMBL13678756 | 0.87 | ALDH1A1 (0.33) | ALDH1A1GAATSHR | |
| SCHEMBL4967863 | 0.81 | PIK3CD (0.30) | ALDH1A1 | |
| SCHEMBL6230430 | 0.79 | LPAR3 (0.40) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2981560-B1 | CURING OF LIQUID THERMOSETTING RESINS | REICHHOLD LLC 2 (US) | 2021-10-13 | — | — | EP | claimed |
| EP-2981560-A1 | CURING OF LIQUID THERMOSETTING RESINS | Reichhold, Inc. (US) | 2016-02-10 | — | — | EP | claimed |
| US-9068045-B2 | Curing of liquid thermosetting resins | REICHHOLD, INC. (US) | 2015-06-30 | — | — | US | claimed |
| WO-2014165425-A1 | CURING OF LIQUID THERMOSETTING RESINS | REICHHOLD, INC. (US) | 2014-10-09 | — | — | WO | claimed |
| US-20140303315-A1 | CURING OF LIQUID THERMOSETTING RESINS | Polynt Composites USA Inc. | 2014-10-09 | — | — | US | claimed |
| EP-0625054-B1 | RADIOPHARMACEUTICAL KITS STABILISED BY CYCLODEXTRINS | MALLINCKRODT INC (US) | 2007-11-14 | — | — | EP | claimed |
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1690552-A2 | Radiopharmaceutical kits stabilised by means of cyclodextrins | Mallinckrodt Inc. (US) | 2006-08-16 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| EP-0692978-A4 | RADIOPHARMACEUTICAL FORMULATIONS HAVING NON-STANNOUS REDUCTANTS | MALLINCKRODT MEDICAL INC (US) | 1998-05-06 | — | — | EP | claimed |
| EP-0625054-A4 | STABILIZED RADIOPHARMACEUTICAL KITS. | MALLINCKRODT MEDICAL INC (US) | 1996-04-17 | — | — | EP | claimed |
| EP-0692978-A1 | RADIOPHARMACEUTICAL FORMULATIONS HAVING NON-STANNOUS REDUCTANTS | MALLINCKRODT MEDICAL, INC. (US) | 1996-01-24 | — | — | EP | claimed |
| EP-0625054-A1 | STABILIZED RADIOPHARMACEUTICAL KITS | MALLINCKRODT MEDICAL, INC. (US) | 1994-11-23 | — | — | EP | claimed |
| WO-1994022496-A1 | RADIOPHARMACEUTICAL FORMULATIONS HAVING NON-STANNOUS REDUCTANTS | MALLINCKRODT MEDICAL, INC. (US) | 1994-10-13 | — | — | WO | claimed |
| EP-0563328-A1 | ?99m Tc(III) MYOCARDIAL IMAGING AGENTS AND METHOD OF USE | MALLINCKRODT MEDICAL, INC. (US) | 1993-10-06 | — | — | EP | claimed |
| WO-1993015765-A1 | STABILIZED RADIOPHARMACEUTICAL KITS | MALLINCKRODT MEDICAL, INC. (US) | 1993-08-19 | — | — | WO | claimed |
| WO-1992011040-A2 | 99mTc(III) MYOCARDIAL IMAGING AGENTS AND METHOD OF USE | MALLINCKRODT MEDICAL, INC. (US) | 1992-07-09 | — | — | WO | claimed |
| US-5112595-A | Diaminoalkyldifuranones and phosphine ligands with technetium for imaging | MALLINCKRODT MEDICAL, INC. (US) | 1992-05-12 | — | — | US | claimed |
| US-5112594-A | Diaminoalkyldifuranones and phosphine ligands with technetium for imaging | MALLINCKRODT MEDICAL, INC. (US) | 1992-05-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | ALDH1A1 4512/4885GAA 3758/4885TSHR 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.